Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the foundations of health care, for global and US citizens alike. What started ...

Tremendous progress in treatment and outcomes has been achieved across the whole range of haematological malignancies in the past two decades. Several haematological malignancies are now chronic ...

Neurological disorders are the leading cause of disease burden, affecting more than 3 billion people worldwide, and the second leading cause of death.1 The burden of neurological disorders is ...

Population breast cancer screening using mammography, alongside effective treatment, has been shown to reduce breast cancer ...

Founded in 1900, the Oswaldo Cruz Foundation has made fundamental contributions to the basic understanding of infectious ...

Water and water infrastructure are being increasingly targeted with impunity in conflicts from Gaza to Ukraine. The effects ...

For more than 80 years, the US Government has invested in biomedical, clinical, and public health research, making it a world ...

Since the COVID-19 pandemic, One Health approaches1 have revived attention to the interdependence of human, animal, and ...

In May, 2025, the World Health Assembly (WHA) will vote on re-establishing a mandate for WHO to address the health ...

New health data regulations promise to empower patients and help research, but can they overcome difficulties in ...

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...